Diabetes Diagnostics

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions and Scope of Study
• Blood Glucose Testing Devices
• Blood Glucose Monitor
• Diabetes Kit
• Diabetes Tracking System
• Blood Glucose Sensor
• Diabetes Testing Supplies
• Blood Glucose Test Strips
• Lancet
• Lancet Device
• Reagent Strips

II. EXECUTIVE SUMMARY

1. Market Overview

• Current & Future Analysis
• Analysis by Geographic Region
• Table 1: Global Market for Diabetes Diagnostics (2000- 2010): Geographic Regions (US, Canada, Japan, Europe, Asia-Pacific and Latin America) Ranked by CAGR (includes corresponding Graph/Chart)
• Analysis by Product Group
• Table 2: Global Market for Diabetes Diagnostics (2000-2010): Product Groups (Blood Glucose Testing Devices, Diabetes Testing Supplies, and Others) Ranked by CAGR (includes corresponding Graph/Chart)
• Major Pharma Players - Focusing on Diabetes Diagnostics
• Increasing Number of Diabetic Cases Drives Demand for Diagnostics
• Prevalence of Diabetes
• Diabetes- Take the Toll in Developing Countries
• Table 3: A Peek into Aging Population Statistics in BRIC Countries by Age Group - 15 to 64 Years and More than 65 Years for the Years 2005 & 2006 (In %) (includes corresponding Graph/Chart)
• Table 4: Worldwide Diabetics Market (2000 & 2025): Percentage Breakdown of Diabetes Incidence by Region - India, China, Brazil, Russia and Others (includes corresponding Graph/Chart)

2. Market Trends

• Focus on Established Procedures Driving Growth
• Insulin Delivery Systems - A Potential High Growth Segment...
• Significant Increase in Number of Diabetics
• Footwear Manufacturers Gaining from Diabetes
• Portable Glucose Meters Fast Replacing Conventional Testing Methods
• Point-of-Care Testing - A Profitable Venture...
• It Pays to be Customer Focused in a Mature Market...
• Competitive Scenario in the Recent Past
• Table 5: Leading Players in the Global Blood Glucose Monitoring Systems Market in the Recent Past (2003 & 2004): Percentage Breakdown of Sales Revenues for Roche Diagnostics, LifeScan (Johnson & Johnson), Bayer, Abbott Diabetes Care, Home Diagnostics and Others (includes corresponding Graph/Chart)
• Table 6: Leading Players in the US Blood Glucose Meters Market in the Recent Past (2003 & 2004): Percentage Breakdown of Sales Revenues for LifeScan (Johnson & Johnson), Roche, Bayer, Abbott Diabetes Care and Others (includes corresponding Graph/Chart)
• Table 7: Leading Players in the US Blood Glucose Strips Market in the recent Past (2003 & 2004): Percentage Breakdown of Sales Revenues for LifeScan (Johnson & Johnson), Roche, Bayer, Abbott Diabetes Care and Others (includes corresponding Graph/Chart)

3. Trends in Diabetes Management

• Rising Population of Diabetics
• Advancements in Glucose Monitoring Devices - A New Ray of Hope
• Innovations in Insulin Delivery
• Pain-Free and Alternate-Site Glucose Monitoring
• Continuous Glucose Monitoring
• Up-to-the-Minute Monitoring
• Advances in Insulin Delivery
• Pulmonary Insulin Delivery
• Jet Injection
• Ultrasonic Transdermal-Patch Technology
• Insulin Delivery via Mouth Spray
• Artificial Pancreas Technology
• Increased Incidence of Diabetes Among HIV+
• Recent Advancements in Diabetes Management
• New Developments
• Recent Advancements in Diabetes Therapy
• Aldose Reductase Inhibitors (ARI)
• Advanced Glycation End-Product Inhibitors (AGEI)

4. Technological Trends

• Innovative Product Design Developments Enhancing Diabetic' s Quality of Life
• Reducing Costs for Managed Care Service Providers - Emerging Trend
• Finding Solutions Through Innovations

5. Bloodless Testing

• High Price - The Only Hurdle
• The World' s First Non-Invasive Glucose Sensor
• Medicare Coverage - A Strong Positive

6. OTC/Physicians' Office Diabetes Tests Market

• In-home Tests: Making Health Control Easier
• Common OTC Tests
• Glucose Monitor
• Cholesterol
• Major Market Segments in OTC/Physicians' Office Diabetes Tests
• Urine Strips
• Blood Glucose Strips: A Well Established Market
• Blood Glucose Meters
• PBGM Devices: Based on Photometric or Biosensor Technology

7. Laboratory Diabetes Tests Market

• Various Types of Laboratory Diabetes Tests
• Blood Glucose & Related Tests
• Fructosamine Tests: To Diagnose Gestational Diabetes
• Glycosylated Hemoglobin Tests: A Promising Approach in Diagnosing Diabetes Mellitus
• Glycosylated Haemoglobin Tests - Paving Way for Early Stage Diabetes Diagnosis
• Immunoassays (Anti-Insulin and Anti-Islet Antibodies)
• It Pays to Introduce Advanced Instruments
• Urine Ketones and Microalbuminuria: To Test Type I Diabetes
• Diabetic Renal Disease with Reference to Microalbuminuria
• All Other Diabetes Tests
• Diabetes Tests
• Fasting Plasma Glucose Test
• Casual Glucose Test

8. Diabetes Diagnostics - An Overview

• Classification
• Blood Glucose Testing Devices
• Blood Glucose Monitor/Meter
• Select Blood Glucose Meters Based on Test Strips
• Select Blood Glucose Monitors Based on Sampling Method
• Diabetes Kit
• Diabetes Tracking System
• Blood Glucose Sensor
• Diabetes Testing Supplies
• Blood Glucose Test Strips
• Lancet
• Lancet Device
• Reagent Strips
• Reagent Tablet

9. Diabetes: A Chronic Body Disorder

• Diabetes Symptoms
• Diabetes: One of the Leading Causes of Death in Developed Countries
• Types of Diabetes
• Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM)
• Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (NIDDM)
• NIDDM Might Lead to Cardiovascular Complications
• Increasing Occurrence of Type II Diabetes Worldwide
• Factors Influencing Type 2 diabetes
• Agents Used For Type2 Diabetes Treatment
• Diabetes: A Major Healthcare Challenge
• Etiological Factors Causing Diabetes
• Insulin Types

10. Diabetes-Related Complications

• Possible Complications of Diabetes
• Microvascular Complications (Small Blood Vessel Damage)
• Macrovascular Complications (Large Blood Vessel Damage)
• Other Complications
• Microvascular Complications (Small Blood Vessel Damage)
• Retinopathy
• Diabetic Neuropathy
• Nephropathy
• Macrovascular Complications (Large Blood Vessel Damage)
• Cardiac Problems
• Hypertension (High Blood Pressure)
• Other Major Complications
• Infections
• Impotence
• Pregnancy Complications
• Other Complications Resulting from Diabetes
• Obesity
• Obsessive Compulsive Disorder
• Foot Ulcers
• Dementia and its Association with Diabetes
• Hypoglycemia
• Diabetic Ketoacidosis
• Undiagnosed Diabetics: More Prone to Cardiovascular Diseases

11. Diabetes Incidence

• Diabetics Cases Worldwide - A Demographic Analysis by Geographic Region
• North America
• United States
• Canada
• Mexico
• Table 8: Prevalence Estimates of Diabetes Mellitus in North America: 2000-2001
• Table 9: Prevalence Estimates of Type 1 Diabetes Mellitus in North America: 2000-2001
• Europe
• Table 10: Prevalence Estimates of Diabetes Mellitus in Europe: 2000-2001
• Table 11: Prevalence Estimates of Type 1 Diabetes Mellitus in Europe: 2000-2001
• Asia-Pacific
• Southeast Asian Region
• Western Pacific Region
• Table 12: Prevalence Estimates of Diabetes Mellitus in South-East Asia: 2000-2001
• Table 13: Prevalence Estimates of Type 1 Diabetes Mellitus in Southeast Asia: 2000-2001
• Table 14: Prevalence Estimates of Diabetes Mellitus in Western Pacific: 2000-2001
• South & Central America
• Type-1 Diabetes
• Type-2 Diabetes
• Prevalence of Complications
• Table 15: Prevalence of Diabetes Complications in South and Central American Region: 2000
• Table 16: Prevalence Estimates of Diabetes Mellitus in South & Central America: 2000-2001
• Table 17: Prevalence Estimates of Type 1 Diabetes Mellitus in South & Central America: 2000-2001
• Rest of World
• Table 18: Prevalence Estimates of Diabetes Mellitus in Africa: 2000-2001
• Table 19: Prevalence Estimates of Type 1 Diabetes Mellitus in Africa: 2000-2001

12. Product Launches/Introductions

• Medtronic, Bayer to Launch Blood Glucose Meter
• Bio-Rad Launches Liquichek™ Diabetic Control
• Home Diagnostics Introduces TRUEread
• Medtronic' s CGMS® iPro™ Receives FDA Approval
• Siemens Introduces the DCA Vantage™ Analyzer
• Arkray Introduces Analyzers for Diabetes Testing
• Bayer Releases Brio® and Breeze® Diabetes Management Systems in South Korea and China
• GenExel-Sein Introduces DUO-CARE™ Home-Use Diabetes Products
• HemoCue Unveils New Testing System for Point of Care Use
• LifeScan Launches Easy-to-Use Glucose Meter
• Roche Rolls Out ACCU-CHEK® Spirit Insulin Pump System
• Novo Nordisk Introduces Simple-to-Use GlucaGen ® HypoKit™
• Biomerica Launches New Diabetes Diagnostic Test...
• Hypoguard Introduces New Glucose Meter...
• Bio-Rad Launches VARIANT™ II TURBO Monitoring System
• Roche Launches Accu-Chek Go for Blood Glucose Monitoring
• Roche Diagnostics Launches Accu-Chek Lancing System
• LifeScan Introduces Glucose Meter in India...
• Abbott Laboratories Introduces Two New Glucose Meters in Europe...
• HDI Launches KetoCare™ Ketone Test Strips
• Roche Diagnostics Unveils Accu-Chek D-TRON Plus
• Abbott Introduces Precision Xtra™ Advanced Diabetes Management System
• Abbott Diabetes Care Launches Precision Xtra™ Blood Glucose Test Strip
• LifeScan Introduces Onetouch Horizon
• Bayer Diagnostics Unveils Ascensia® CONTOUR™ Blood Glucose Monitoring System

13. Recent Industry Activity

• OPG Acquires Hahn & Hahn
• Nanobac Agrees to Acquire DNAPrint Genomics
• Novo Nordisk' s R&D Plans in India
• NationsHealth Acquires Diabetes Care & Education
• Inverness Acquires Cholestech
• WaveSense Launches European Subsidiary
• XMDC, Diabetes Detection Sign on Distribution Agreement
• IQMC Agrees on Acquisition of Lifecare AS
• Bayer' s Contour TS Test Strip Market Recall
• BBI Acquires CDx and Audiometrics
• Bayer Receives Ease-Of-Use Commendation for Ascensia® BREEZE® Blood Glucose Monitoring System
• BYETTA® (exenatide) Receives Marketing Authorization from European Commission
• Bayer Diabetes Care Acquires Metrika
• BD Walks Out of BGM Market
• Bio-Rad Acquires Provalis' Medical Diagnostics Division
• Bio-Rad Inks Multi-Year Agreement with Premier
• Cholestech and Life Line Collaborate Over Diagnostic Testing
• FDA Approves Medtronic' s MiniMed Paradigm® RT CGM System
• FDA Clears Abbott' s FreeStyle® Freedom™ Blood Glucose Meter
• FDA Approves Hypoguard' s Blood Glucose Monitor
• FDA Approves DexCom' s Continuous Glucose Monitoring System
• Johnson & Johnson Acquires Animas Corporation
• LifeScan and NIR Agree on Extension of First Option Agreement
• Pfizer Obtains Global Rights to Inhalable Human Insulin - Exubera®
• Roche Receives FDA Clearance for Acu-Check Insulin Pump
• Sphere Medical and Analogic Team up for Monitoring Solutions
• NeuroMetrix Wins Exclusive Marketing License of DigiScope
• FDA Recommends Exubera® for Diabetic Patients
• Bio-Rad and Sysmex Ink Co-Marketing Agreement
• Diabetes Gold Forms Joint Venture with BioTex Labs
• FDA Grants 510(k) Clearance for Abbott' s Freestyle Connect™ Blood Glucose Meter
• FDA Clears Hypoguard' s Advance Micro-draw™ Blood Glucose System
• FDA Approves Home Diagnostics' Blood Glucose Testing System
• Insulet Corporation and Solectron Collaborate to Develop OmniPod™
• PolyMedica Acquires National Diabetic Pharmacies
• Cygnus, Inc. Divests its Glucose-Monitoring Assets
• Home Diagnostics' Blood Glucose Monitor Features in Best Rx Value Drug List of Ohio
• Roche Diagnostics Receives US FDA Approval for its Latest Blood Glucose Meter...
• Provalis Ships in2it A1C to US
• Hitachi Develops Unique Non-Invasive Device for Diabetes Monitoring
• Bayer Diagnostics Business Splits into Two Units...
• Abbott Laboratories Acquires TheraSense Inc.
• Roche Acquires Infusion Systems Division of Disetronic
• Bristol-Myers Squibb Enters into Alliance with Merck
• Provalis Receives FDA Approval...
• Gunze Enters into an Agreement with Sanko Junyaku Strike
• Health Hero Network Receives US FDA Approval...
• Roche Diagnostics Corporation Receives Contract from Premier Inc
• Vitro Introduces Stem Cell Therapy for Diabetes...
• Home Diagnostics' Blood Glucose Monitor Features in RxAmerica National Formulary...
• Home Diagnostics' Blood Glucose Monitor Features in Procare Rx National Formulary...
• Medtronic Receives FDA Approval for its New Continuous Glucose Monitoring System
• Roche Diagnostics Awarded Blood Glucose and Lancet Contracts...
• HDI' s TrueTrack Smart System Wins FDA Approval for AST
• Seradyn Bags US FDA Clearance for HbA1c Assay
• Bristol-Myers Squibb Receives Exclusive Rights to AlcNow Diabetes Monitor
• Bio-Rad Laboratories Awarded 510(k) Clearance for VARIANT™ II TURBO

14. Focus on Select Players

• Abbott Diabetes Care (US)
• Bayer HealthCare (US)
• Bayer Diabetes Care (US)
• Metrika, Inc. (US)
• Bio-Rad Laboratories (US)
• Home Diagnostics, Inc. (US)
• Inverness Medical Innovations, Inc (US)
• LifeScan, Inc. (US)
• Medtronic MiniMed, Inc. (US)
• Roche Diagnostics (Switzerland)
• Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
• Siemens Healthcare Diagnostics (US)

15. Global Market Perspective

• Table 20: World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 21: World Long-term Projections for Diabetes Diagnostics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 22: World 10-Year Perspective for Diabetes Diagnostics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 23: World Recent Past, Current & Future Analysis for Blood Glucose Testing Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 24: World Long-term Projections for Blood Glucose Testing Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 25: World 10-Year Perspective for Blood Glucose Testing Devices by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 26: World Recent Past, Current & Future Analysis for Blood Glucose Testing Devices by Product Segment - Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 27: World Long-term Projections for Blood Glucose Testing Devices by Product Segment - Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 28: World 10-Year Perspective for Blood Glucose Testing Devices by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 29: World Recent Past, Current & Future Analysis for Blood Glucose Test Kits by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 30: World Long-term Projections for Blood Glucose Test Kits by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 31: World 10-Year Perspective for Blood Glucose Test Kits by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 32: World Recent Past, Current & Future Analysis for Blood Glucose Meters/Monitors by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 33: World Long-term Projections for Blood Glucose Meters/ Monitors by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 34: World 10-Year Perspective for Blood Glucose Meters/Monitors by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 35: World Recent Past, Current & Future Analysis for Diabetes Kits by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 36: World Long-term Projections for Diabetes Kits by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 37: World 10-Year Perspective for Diabetes Kits by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 38: World Recent Past, Current & Future Analysis for Diabetes Tracking Systems by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 39: World Long-term Projections for Diabetes Tracking Systems by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 40: World 10-Year Perspective for Diabetes Tracking Systems by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 41: World Recent Past, Current & Future Analysis for Diabetes Testing Supplies by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 42: World Long-term Projections for Diabetes Testing Supplies by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 43: World 10-Year Perspective for Diabetes Testing Supplies by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 44: World Recent Past, Current & Future Analysis for Diabetes Testing Supplies by Product Segment - Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, and Blood Glucose Insta Glucose Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 45: World Long-term Projections for Diabetes Testing Supplies by Product Segment - Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, and Blood Glucose Insta Glucose Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 46: World 10-Year Perspective for Diabetes Testing Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, and Blood Glucose Insta Glucose Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 47: World Recent Past, Current & Future Analysis for Blood Glucose Test Strips by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 48: World Long-term Projections for Blood Glucose Test Strips by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 49: World 10-Year Perspective for Blood Glucose Test Strips by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 50: World Recent Past, Current & Future Analysis for Lancets by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 51: World Long-term Projections for Lancets by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 52: World 10-Year Perspective for Lancets by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 53: World Recent Past, Current & Future Analysis for Lancet Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 54: World Long-term Projections for Lancet Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 55: World 10-Year Perspective for Lancet Devices by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 56: World Recent Past, Current & Future Analysis for Reagent Strips by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 57: World Long-term Projections for Reagent Strips by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 58: World 10-Year Perspective for Reagent Strips by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012(includes corresponding Graph/Chart)
• Table 59: World Recent Past, Current & Future Analysis for Blood Glucose Insta Glucose by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 60: World Long-term Projections for Blood Glucose Insta Glucose by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 61: World 10-Year Perspective for Blood Glucose Insta Glucose by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 62: World Recent Past, Current & Future Analysis for Other Diabetes Diagnostic Products/Supplies by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 63: World Long-term Projections for Other Diabetes Diagnostic Products/Supplies by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 64: World 10-Year Perspective for Other Diabetes Diagnostic Products/Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Current and Future Analysis
  • Diabetes: A Leading Cause of Death in the US
  • Market Trends
  • Companies Focus on Research for Better Diabetes Diagnostics
  • Focus on Established Procedures Driving Growth
  • Insulin Delivery Systems - A Potential High Growth Segment
  • Leading Players' Market Shares in the Recent Past
  • Table 65: Leading Players in the US Blood Glucose Meters Market in the Recent Past (2003 & 2004): Percentage Breakdown of Sales Revenues for LifeScan (Johnson & Johnson), Roche, Bayer, Abbott Diabetes Care and Others (includes corresponding Graph/Chart)
  • Table 66: Leading Players in the US Blood Glucose Strips Market in the recent Past (2003 & 2004): Percentage Breakdown of Sales Revenues for LifeScan (Johnson & Johnson), Roche, Bayer, Abbott Diabetes Care and Others (includes corresponding Graph/Chart)
  • Complications Associated with Diabetes
  • Heart Disease
  • Stroke
  • High Blood Pressure
  • Blindness
  • Kidney Disease
  • Nerve Disease
  • Amputations
  • Dental Disease
  • Pregnancy
  • Table 67: Prevalence Estimates of Diabetes Mellitus in North America: 2000-2001
  • Table 68: Prevalence Estimates of Type 1 Diabetes Mellitus in North America: 2000-2001
  • Product Launches/Introductions
  • Strategic Corporate Developments
  • Select US Players
• B. Market Analytics
  • Table 69: US Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 70: US Long-term Projections for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/ Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 71: US 10-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2. Canada

• A. Market Analysis
  • Current and Future Analysis
  • Diabetes Incidence
• B. Market Analytics
  • Table 72: Canadian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 73: Canadian Long-term Projections for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 74: Canadian 10-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

3. Japan

• A. Market Analysis
  • Current and Future Analysis
  • Growing Aging Population
  • Miscellaneous Trends Influencing Diabetes Diagnostics Market
  • Product Launch
  • Strategic Corporate Developments in Recent Past
  • Sanwa Kagaku Kenkyusho Co, Ltd. - A Select Player
• B. Market Analytics
  • Table 75: Japanese Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 76: Japanese Long-term Projections for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/ Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 77: Japanese 10-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4. Europe

• A. Market Analysis
  • Current and Future Analysis
  • A Regional Perspective
  • Analysis by Product Groups/Segments
  • Market Trends
  • Significant Increase in Number of Diabetics
  • Portable Glucose Meters Fast Replacing Conventional Testing Methods
  • Point-of-Care Testing - A Profitable Venture...
  • It Pays to be Customer Focused in a Mature Market
  • Diabetes Incidence in Recent Past
  • Table 78: Prevalence Estimates of Diabetes Mellitus in Europe: 2000-2001
  • Table 79: Prevalence Estimates of Type 1 Diabetes Mellitus in Europe: 2000-2001
  • Product Launches//Introductions
  • Strategic Corporate Developments
  • Roche Diagnostics (Switzerland) - A Select Player
• B. Market Analytics
  • Table 80: European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 81: European Long-term Projections for Diabetes Diagnostics by Geographic Region/Country - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 82: European 10-Year Perspective for Diabetes Diagnostics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 83: European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 84: European Long-term Projections for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 85: European 10-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4a. France

• Market Analysis
• Current and Future Analysis
• Table 86: French Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 87: French Long-term Projections for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 88: French 10-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4b. Germany

• A. Market Analysis
  • Current and Future Analysis
  • Strategic Corporate Development
• B. Market Analytics
  • Table 89: German Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 90: German Long-term Projections for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 91: German 10-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4c. Italy

• Market Analysis
• Current and Future Analysis
• Table 92: Italian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 93: Italian Long-term Projections for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 94: Italian 10-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4d. The United Kingdom

• Market Analysis
• Current and Future Analysis
• Table 95: UK Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 96: UK Long-term Projections for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 97: UK 10-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4e. Rest of Europe

• Market Analysis
• Current and Future Analysis
• Table 98: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 99: Rest of Europe Long-term Projections for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/ Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 100: Rest of Europe 10-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

5. Asia-Pacific

• A. Market Analysis
  • Current and Future Analysis
  • Public and Private Sector Diabetes Care
  • Public Sector
  • Private Sector
  • Cost Prohibits Penetration of Continuous Monitoring Devices
  • Role of Healthcare Societies and Associations
  • India
  • Bangladesh
  • Western Pacific Declaration on Diabetes
  • India
  • Market Overview
  • Glucometer Prices on the Downward Spiral
  • Market Restraints
  • Diabetes Incidence in Recent Past
  • Southeast Asian Region
  • Western Pacific Region
  • Table 101: Prevalence Estimates of Diabetes Mellitus in South-East Asia: 2000-2001
  • Table 102: Prevalence Estimates of Type 1 Diabetes Mellitus in Southeast Asia: 2000-2001
  • Table 103: Prevalence Estimates of Diabetes Mellitus in Western Pacific: 2000-2001
  • Product Launches//Introductions
  • Strategic Corporate Development
• B. Market Analytics
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2000 through 2010 includes corresponding Graph/Chart)
  • Table 105: Asia-Pacific Long-term Projections for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/ Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 106: Asia-Pacific 10-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

6. Latin America

• A. Market Analysis
  • Current and Future Analysis
  • National Diabetes Programs
  • Guidelines for Diabetes Care
  • Diabetes Incidence in Recent Past
  • Type-1 Diabetes
  • Type-2 Diabetes
  • Prevalence of Complications
  • Table 107: Prevalence of Diabetes Complications in South and Central American Region: 2000
  • Table 108: Prevalence Estimates of Diabetes Mellitus in South & Central America: 2000-2001
  • Table 109: Prevalence Estimates of Type 1 Diabetes Mellitus in South & Central America: 2000-2001
  • Strategic Corporate Development in Recent Past
• B. Market Analytics
  • Table 110: Latin American Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 111: Latin American Long-term Projections for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 112: Latin American 10-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

7. Rest of World

• A. Market Analysis
  • Current and Future Analysis
  • Diabetes Incidence in Recent Past
  • Table 113: Prevalence Estimates of Diabetes Mellitus in Africa: 2000-2001
  • Table 114: Prevalence Estimates of Type 1 Diabetes Mellitus in Africa: 2000-2001
  • Table 115: Prevalence Estimates of Diabetes Mellitus in Eastern Mediterranean and Middle East: 2000-2001
  • Table 116: Prevalence Estimates of Type 1 Diabetes Mellitus in Eastern Mediterranean and Middle East: 2000-2001
• B. Market Analytics
  • Table 117: Rest of World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 118: Rest of World Long-term Projections for Diabetes Diagnostics by Product Segment - Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 119: Rest of World 10-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking System) and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose) and Other Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE